文献速递神经肿瘤

WHO I级乳头状胶质神经元肿瘤的5-ALA荧光:一例病例报告

5-ALA fluorescence in a WHO grade I papillary glioneuronal tumour: a case report.
PubMed 文献 · Acta Neurochir (Wien) · 2020-01-27

一例49岁女性左颞叶病变,2004年偶然发现后随访,2016年出现对比增强但无症状拒绝手术,2018年出现环形强化、血管源性水肿增加和灌注增高后接受手术。术中使用5-ALA,肿瘤在蓝光400滤镜下呈明亮荧光,明亮和淡荧光均被切除,术后MRI显示完全切除,病理为WHO I级乳头状胶质神经元肿瘤,BRAF V600突变阴性。

要点

  • WHO I级乳头状胶质神经元肿瘤可表现为5-ALA荧光病变。
  • 5-ALA可用于实现此类病变的完全切除,多数病例可治愈。
  • 5-ALA在WHO I级病变中的应用仍存争议。

核心结论

  • WHO I级乳头状胶质神经元肿瘤可表现为5-ALA荧光病变,从临床角度5-ALA可用于实现完全切除,多数病例可治愈。

研究设计与样本

  • 病例报告:一例49岁女性左颞叶病变患者,2004年偶然发现,随访至2018年接受手术。

主要发现

  • 2016年病变显示对比增强,患者无症状拒绝手术;2018年病变显示环形对比增强、血管源性水肿增加和灌注增高,患者接受手术。
  • 术中使用5-ALA,肿瘤在Blue 400滤镜-Zeiss Pentero 900下呈明亮荧光,明亮荧光和淡荧光均被切除。
  • 术后MRI显示完全切除,组织病理学为WHO I级乳头状胶质神经元肿瘤,BRAF V600突变阴性。

临床怎么用

  • 作者认为,从临床角度5-ALA可用于实现此类病变的完全切除,多数病例可治愈。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

5-ALA is proven to be effective in high-grade glioma operative resection. The use of 5-ALA in WHO grade I lesions is still controversial. A 49-year-old lady was diagnosed in 2004 with a left temporal lobe lesion as an incidental finding; she was followed up clinically and radiologically. In 2016, the lesion showed contrast enhancement and she was offered surgical resection but given she is asymptomatic, she refused. In 2018, the lesion showed signs of transformation with ring contrast enhancement, increased vasogenic oedema and perfusion; the patient accepted surgery at that point. She had preoperative mapping by navigated transcranial magnetic stimulation and she had operative resection with 5-ALA. The tumour was bright fluorescent under Blue 400 filter-Zeiss Pentero 900©(Carl Zeiss Meditec)-and both bright fluorescence and pale fluorescence were resected. Postoperative MRI showed complete resection and histopathology revealed WHO grade I papillary glioneuronal tumour, negative for BRAF V600 mutation. WHO grade I papillary glioneuronal tumour may present as 5-ALA fluorescent lesions. From a clinical perspective, 5-ALA can be used to achieve complete resections in these lesions which, in most cases, can be curative.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Lavrador JP, Kandeel HS, Kalb A, et al. 5-ALA fluorescence in a WHO grade I papillary glioneuronal tumour: a case report. Acta Neurochir (Wien). 2020. PMID: 31989247. doi:10.1007/s00701-020-04223-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。